Nilemdo Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Description

Nilemdo film-coated tablets are white to off-white, oval, approximately 13.97 mm × 6.60 mm × 4.80 mm, debossed with "180" on one side and "ESP" on the other side.
Each film-coated tablet contains 180 mg of bempedoic acid.
Excipient(s) with known effect: Each 180 mg film-coated tablet contains 28.5 mg of lactose.
Excipients/Inactive Ingredients: Tablet core: Lactose monohydrate, Microcrystalline cellulose (E460), Sodium starch glycolate (Type A grade), Hydroxypropyl cellulose (E463), Magnesium stearate (E470b), Colloidal anhydrous silica (E551).
Film-coating: Partially hydrolysed poly(vinyl alcohol) (E1203), Talc (E553b), Titanium dioxide (E171), Macrogol/PEG (E1521).

bempedoic acid

Manufacturer:

Daiichi Sankyo

Distributor:

Zuellig

Agencia Lei Va Hong